COVID-19 in Liver Transplant Recipients
Authors:
- Ravina KullarRKRavina Kullar
- Ankur Prakash PatelAPAnkur Prakash Patel
- Sammy SaabSSSammy Saab
Open Access
- 22 February 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Abstract
Coronavirus disease 2019 (COVID-19) has infected over 93 million people worldwide as of January 14, 2021. Various studies have gathered data on liver transplant patients infected with COVID-19. Here, we discuss the presentation of COVID-19 in immunosuppressed patients with prior liver transplants. We also evaluate patient outcomes after infection.Keywords
This publication has 26 references indexed in Scilit:
- Early impact of COVID-19 on transplant center practices and policies in the United StatesAmerican Journal of Transplantation, 2020
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- Liver transplantation around the worldLiver Transplantation, 2016
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013
- Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical TrialsAmerican Journal of Transplantation, 2011
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJAMA, 1999